임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1상모집 중단 (진행 중)· Pneumonia, BacterialTrial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
리드: GSK
- 2상모집 중단 (진행 중)· Influenza, HumanA Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
리드: GSK
- 1상모집 중단 (진행 중)· Hepatitis BA Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
리드: GSK
- 1/2상모집 중단 (진행 중)· MelanomaA Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
리드: GSK
- 1상모집 중단 (진행 중)· Colitis, UlcerativeA First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
리드: GSK
- 2상모집 중단 (진행 중)· Chronic Hepatitis B Virus InfectionA Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
리드: GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
리드: GSK
- 1상모집 중단 (진행 중)· Respiratory Syncytial Virus InfectionsA Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years
리드: GSK
- 2상모집 중단 (진행 중)· Plasma Cell MyelomaBelantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
협력: GSK
- 3상모집 중단 (진행 중)· Respiratory Syncytial Virus InfectionsAn Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study
리드: GSK
- 3상모집 중단 (진행 중)· GlioblastomaA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
협력: GSK
- 1/2상모집 중단 (진행 중)· Myeloid LeukemiaA Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
협력: GSK
- 1/2상모집 중단 (진행 중)· Recurrent Vulvovaginal CandidiasisAssessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
협력: GSK
- 1상모집 중단 (진행 중)· Pulmonary Disease, Chronic ObstructiveA Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
리드: GSK
- 단계 미표기모집 중단 (진행 중)· Endometrial CancerMolecular and Epidemiological Characteristics of Endometrial Cancer in Brazil
협력: GSK
- 1/2상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaTwo-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
협력: GSK
- 4상모집 중단 (진행 중)· Meningitis, MeningococcalA Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
리드: GSK
- 2상모집 중단 (진행 중)· Alzheimer's DiseaseEfficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
리드: GSK
- 단계 미표기모집 중단 (진행 중)· Ovarian CancerA Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
협력: GSK
- 단계 미표기모집 중단 (진행 중)· Respiratory Syncytial Virus (RSV)Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
협력: GSK
- 4상모집 중단 (진행 중)· Rheumatoid ArthritisRecombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
협력: GSK
- 단계 미표기모집 중단 (진행 중)· Severe AsthmaUsing NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System
협력: GSK
- 2상모집 중단 (진행 중)· Neoplasms, RectalA Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
리드: GSK
- 4상모집 중단 (진행 중)· AsthmaSymptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
협력: GSK
- 단계 미표기모집 중단 (진행 중)· Multiple Myeloma in RelapseImpact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
협력: GSK
- 2상모집 중단 (진행 중)· Nonalcoholic Fatty Liver DiseasePhase 2b Study of GSK4532990 in Adults With NASH
리드: GSK
- 2상모집 중단 (진행 중)· Lung Cancer, Non-Small CellA Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
리드: GSK
- 2상모집 중단 (진행 중)· Sarcoma,Soft TissueA Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
협력: GSK
- 3상모집 중단 (진행 중)· Herpes ZosterA Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
리드: GSK
- 3상모집 중단 (진행 중)· AsthmaEvaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
협력: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaSub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
리드: GSK
- 3상모집 중단 (진행 중)· Eosinophilic Granulomatosis With PolyangiitisEfficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
리드: GSK
- 단계 미표기모집 중단 (진행 중)· Herpes ZosterSafety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions
리드: GSK
- 3상모집 중단 (진행 중)· Endometrial CancerEndometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
협력: GSK
- 1상모집 중단 (진행 중)· NeoplasmsFirst-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
리드: GSK
- 1/2상모집 중단 (진행 중)· Multiple MyelomaNovel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
협력: GSK
- 2상모집 중단 (진행 중)· Chronic Lymphoid Leukemia in RelapseBelimumab in Patients with Chronic Lymphocytic Leukemia
협력: GSK
- 2상모집 중단 (진행 중)· Meningitis, MeningococcalSafety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents
리드: GSK
- 초기 1상모집 중단 (진행 중)· GlioblastomaTrial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
협력: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.